Science ❯ Psychology

Psychedelics

Therapeutic Effects Research Clinical Trials Therapeutic Use Therapeutic Applications Psilocybin Drug Development Research Methods Drug Research Substance Use Disorders Ibogaine Effects DMT Neuroscience LSD Research Methodology Effects on Mind

Definium’s Oral LSD Pill Meets Primary Endpoint in Phase 3 Depression Trial

Topline data could support an expedited FDA filing as a second confirmatory Phase 3 trial continues.

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

Single High Dose of Psilocybin Tied to Lasting Brain Changes and Month-Later Well-Being

Trump Order to Speed Psychedelic Therapies Sends Compass Pathways to 52-Week High

New Analysis Finds Psychedelic Therapy Matches Antidepressants for Major Depression

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Single IV Dose of DMT Shows Rapid, Lasting Antidepressant Effects in Small Trial

Single Psilocybin Dose Plus Mindfulness Eases Depression for Frontline Clinicians in Randomized Trial

Single Psilocybin Dose Offers Long-Term Relief for Cancer-Related Depression

Single Psilocybin Dose Delivers Two-Year Relief From Depression and Anxiety in Cancer Patients

Global Experts Release ReSPCT Guidelines to Standardize Psychedelic Trial Reporting